Indian law firm S&R Associates has advised Glenmark Pharmaceuticals on the proposed divestment of 75 percent stake in Glenmark Life Sciences (GLS) for $680 million to Nirma, which was represented by Khaitan & Co.

GLS, which is a manufacturer and supplier of Active Pharmaceutical Ingredients (APIs) to global pharma manufacturers, was advised by Trilegal.

Pursuant to the transaction, Nirma will make a mandatory open offer to all public stakeholders of GLS. Glenmark Pharma will continue to own 7.84 percent of GLS.

The S&R team representing Glenmark Pharma was led by corporate partners Rajat Sethi and Pratichi Mishra, and included antitrust head Simran Dhir, tax partner Sumit Bansal and banking and finance partner Divyanshu Pandey.

The Khaitan team that represented Nirma was led by M&A partners Aashutosh Sampat and Mehul Shah and also included partners Arindam Ghosh (securities), Anisha Chand and Anshuman Sakle (competition), Shailendra Bhandare (IP), Abhiraj Gandhi (real estate) and Deepak Kumar (employment).

The Trilegal team representing GLS was led by the head of the corporate group, Yogesh Singh, along with partners Tejas Adiga and Atul Gupta.

“This deal aligns with our strategic intent of moving up the value chain to become an innovative/brand-led organisation, with continuous focus on our core therapeutic areas of dermatology, respiratory and oncology. It also presents an opportunity for us to strengthen shareholder value through deleveraging and enhancing our overall return profile,” Glenn Saldanha, chairman and managing director of Glenmark Pharma, said in a statement.

GLS will continue to operate as an independent API company under Nirma Limited, Yasir Rawjee, managing director and CEO of GLS, added.



Related Articles

STB, S&C, Freshies act on $8 bln cross-border AC assets deal

Sullivan & Cromwell has advised German engineering group Robert Bosch on its $8 billion agreement to acquire the residential ventilation businesses of Johnson Controls and Japanese group Hitachi.

S&C, Freshies guide $905 mln U.S.-Japan tire deal

U.S. law firm Sullivan & Cromwell is advising Goodyear Tire & Rubber on the planned sale of its Off-the-Road equipment tire business to Japan's Yokohama Rubber, which is being represented by Freshfields Bruckhaus Deringer.

A&O Shearman advises Allianz on $1.6 bln Singapore insurance deal

by Nimitt Dixit |

A&O Shearman has advised German insurer Allianz on the acquisition of a 51 percent stake in Singapore's Income Insurance for S$2.2 billion ($1.6 billion), the latest major deal in Singapore’s buzzing insurance sector.